BrainMap

Ms. ALINA ADRIANA MINEA

dr. habil.

professor - UNIVERSITATEA TEHNICĂ "GHEORGHE ASACHI" IAŞI

Researcher | Teaching staff | Scientific reviewer

ResearcherID: C-7307-2009

Curriculum Vitae (26/06/2018)

Expertise & keywords

ANTITUMORAL THERANOSTIC PLATFORMS BASED ON CARBON DOTS AND POLYMER MATRICES Call name: P 1 - SP 1.2 - Proiecte complexe realizate in consorții CDI
PN-III-P1-1.2-PCCDI-2017-0083 2018 - 2020

Role in this project:

Coordinating institution: UNIVERSITATEA TEHNICĂ "GHEORGHE ASACHI" IAŞI

Project partners: UNIVERSITATEA TEHNICĂ "GHEORGHE ASACHI" IAŞI; INSTITUTUL DE CHIMIE MACROMOLECULARA "PETRU PONI"; INSTITUTUL REGIONAL DE ONCOLOGIE IAŞI; INSTITUTUL NATIONAL DE CERCETARE-DEZVOLTARE PENTRU FIZICA TEHNICA-IFT IASI

Affiliation: UNIVERSITATEA TEHNICĂ "GHEORGHE ASACHI" IAŞI

Project website: http://www.ch.tuiasi.ro/cercetare/proiecte/TERADOT/

Abstract:

The TERADOT consortium will implement this project with the aim of reaching its strategic objective: the consolidation of the consortium scientific and technical competencies (in particular those of the P3 partner with relaunch potential) in the field of econanotechnologies and advanced materials by supporting / developing the existing research competences and the transferability of its research results. The TERADOT Consortium is an alliance that will devote its efforts to capitalize the potential of nanotechnologies by creating new teranostic platforms based on Carbon Dots (CDs) in order to radically change the proceedings to diagnose and treat cancer. Building on the significant preliminary results obtained by the project's members, the consortium represents a systematized initiative, comprising four public sector institutions, having the potential to be expanded with private-sector entities, designed to accelerate the application of these new concepts of cancer diagnosis / treatment. The project consists of three distinct subprojects aiming at: 1. Obtaining and testing of some CDs-type nanostructures starting from imidic precursors, suitable as teranostic investigation / anti-tumor treatment platforms; 2. Obtaining and testing of polymeric biocomposites containing imidic CDs, suitable as teranostic investigation / anti-tumor treatment platforms; and 3. Developing a pilot-scale process for synthesizing CD-type nanosciences for medical applications. The TERADOT project proposes to achieve these objectives by accomplishing several specific output indicators, of which the most important are: the employment of eight young researchers, obtaining 4 new products, 1 new technology for CDs preparation, minimum 8 articles in high impact journals, 5 patent requests (4 national and 1 international) which will further facilitate the collaboration with economic entities as potential beneficiaries.

Overcoming Barriers to Nanofluids Market Uptake Call name:
-

Role in this project: Partner team leader

Coordinating institution: Universitat Jaume I

Project partners:

Affiliation:

Project website: http://www.cost.eu/COST_Actions/ca/CA15119

Abstract:

Nanofluids are defined as fluids that contain nanometre-sized particles with enhanced heat transfer properties. Since 1995, active research on this topic has been conducted (more than 1,700 papers in the last 3 years). Nanofluids improve the efficiency of heat exchange and thermal energy storage systems and they are specifically mentioned in the Strategic Energy Technology Plan and the Materials Roadmap to enable Low-Carbon Technologies as potential elements to improve the efficiency of heat exchange and thermal energy storage systems. Consequently, nanofluids address the European Horizon 2020 Energy and Climate objectives (Societal Challenges 3: Secure, efficient and clean energy; and 6: Climate action, environment, resource efficiency and raw materials). In addition, nanofluids fall within one of the Key Enabling Technologies (KET) supported by the European Commission. Although some nanofluid commercial applications currently exist, most of the current nanofluids are at Technological Readiness Levels (TRL) 1 to 3. Most of the nanofluids research in COST countries has been conducted by Research, Development and Innovation (R+D+i) centres through national funding. Additional coordinated research and development efforts are required to develop nanofluids up to higher TRL levels and to overcome commercial application barriers. If these barriers are overcome, nanofluids will be an important player in the Value Added Materials (VAM) for the energy sector.The objective of the NANOUPTAKE COST Action is to create a Europe-wide network of leading R+D+i institutions, and of key industries, to develop and foster the use of nanofluids as advanced heat transfer/thermal storage materials to increase the efficiency of heat exchange and storage systems.

FILE DESCRIPTION	DOCUMENT
List of research grants as project coordinator or partner team leader
Significant R&D projects for enterprises, as project manager
R&D activities in enterprises
Peer-review activity for international programs/projects	Download (11.67 kb) 20/03/2017